NHI to release Q2FY26 earnings on August 10, 2026

1 min read     Updated on 16 Jul 2026, 04:02 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

National Health Investors, Inc. scheduled the release of its Q2FY26 earnings for August 10, 2026, followed by a conference call on August 11 at 8:30 a.m. ET. The company provided dial-in and webcast details for investors to access the discussion live or via replay for one year.

powered bylight_fuzz_icon
45700360

*this image is generated using AI for illustrative purposes only.

National Health Investors, Inc. (NHI) announced it will release its financial results for the second quarter ended June 30, 2026, after the market closes on Monday, August 10, 2026. The company will host a conference call on Tuesday, August 11, 2026, at 8:30 a.m. Eastern Time to discuss the quarterly performance.

Investors can access the interactive teleconference by dialing (888) 506-0062 and using the access code 813991. The live broadcast will also be available online at www.nhireit.com and via a specific webcast link.

An online replay of the conference call will be made available shortly after the conclusion of the event and will remain accessible for one year. This allows stakeholders to review the management's discussion regarding the financial outcomes at their convenience.

Conference Call Details

The following table outlines the key schedule and access information for the earnings announcement:

Event Date and Time Access Details
Earnings Release August 10, 2026 (After market close) N/A
Conference Call August 11, 2026 at 8:30 a.m. ET Phone: (888) 506-0062
Code: 813991
Live Webcast August 11, 2026 at 8:30 a.m. ET www.nhireit.com
Online Replay Available shortly after call Available for one year

About National Health Investors, Inc.

National Health Investors, Inc. is a self-managed real estate investment trust established in 1991. The company specializes in sale-leaseback, joint venture, mortgage, and mezzanine financing for senior housing and medical facility investments. NHI operates through two reportable segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). Its portfolio includes independent living facilities, assisted living and memory care communities, entrance-fee retirement communities, senior living campuses, skilled nursing facilities, and specialty hospitals.

What key performance indicators will investors focus on during the Q2 2026 earnings call?

How might NHI's financial results impact its dividend policy for the remainder of 2026?

What trends in the senior housing market could influence NHI's portfolio performance in the coming quarters?

like18
dislike

Deutsche Bank lowers National Health Investors target to $80

0 min read     Updated on 25 Jun 2026, 11:22 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Deutsche Bank analyst Omotayo Okusanya maintained a Hold rating on National Health Investors (NYSE: NHI) and lowered the price target to $80 from $85. The revision signals a tempered outlook for the healthcare real estate investment trust's stock performance despite the continued neutral stance.

powered bylight_fuzz_icon
43955513

*this image is generated using AI for illustrative purposes only.

Deutsche Bank analyst Omotayo Okusanya maintained a Hold rating on National Health Investors (NYSE: NHI) and lowered the price target to $80 from $85. The revision signals a tempered outlook for the healthcare real estate investment trust's stock performance despite the continued neutral stance.

The decision to reduce the price target comes as the firm reassesses the company's valuation and market position. While the Hold rating suggests that the stock is expected to perform in line with the broader market, the lower target indicates a shift in the expected price trajectory.

National Health Investors specializes in financing healthcare real estate. The company's portfolio includes senior housing and post-acute care facilities, which are sensitive to interest rate changes and healthcare utilization trends.

The following table summarizes the rating changes:

Metric Previous New
Rating Hold Hold
Price Target $85 $80

Investors holding National Health Investors shares will note that the revised target price reflects updated projections from Deutsche Bank. The stock continues to trade on the NYSE under the ticker symbol NHI.

What specific valuation metrics or market conditions prompted Deutsche Bank to lower the price target while maintaining a Hold rating?

How might potential interest rate changes in the coming months impact National Health Investors' portfolio of senior housing and post-acute care facilities?

Are there emerging healthcare utilization trends that could significantly affect NHI's performance in the near future?

like19
dislike

More News on National Health Investors Inc